MRNA - CIK 0001682852
Moderna, Inc. (MRNA) reported revenue of $1.94B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $1.94B | -39.9% |
| FY 2024 | $3.24B | -52.7% |
| FY 2023 | $6.85B | -64.4% |
| FY 2022 | $19.26B | +4.3% |
| FY 2021 | $18.47B | +2200.2% |
| FY 2020 | $803.00M | +1238.3% |
| FY 2019 | $60.00M | -55.6% |
| FY 2018 | $135.07M | -34.4% |
| FY 2017 |
Moderna, Inc. (MRNA) reported revenue of $1.94B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Moderna, Inc.'s revenue grew from $108.40M to $1.94B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $205.82M |
| +89.9% |
| FY 2016 | $108.40M | - |